The Importance of Patient-Centered Treatment in MPNs

Kapila Viges, of the MPN Research Foundation, and John Mascarenhas, MD, of the Icahn School of Medicine, discuss the critical need to align patient and physician treatment goals in myeloproliferative neoplasms (MPNs). A recent MPN Research Foundation survey of 600 patients and caregivers revealed that 70% of respondents prioritized stopping or slowing disease progression as their top goal. This highlights the importance of incorporating patient perspectives into treatment decisions. Watch as Viges and Dr. Mascarenhas explore strategies to enhance patient-centered care in MPN management.